↓ Skip to main content

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study

Overview of attention for article published in BMC Musculoskeletal Disorders, April 2012
Altmetric Badge

Mentioned by

facebook
3 Facebook pages

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
Published in
BMC Musculoskeletal Disorders, April 2012
DOI 10.1186/1471-2474-13-61
Pubmed ID
Authors

Stephen Coleman, David Gilpin, James Tursi, Greg Kaufman, Nigel Jones, Brian Cohen

Abstract

Dupuytren's contracture (DC) is a progressive fibroproliferative disorder characterized by development of nodules and collagen cords within the palmar fascia of the hand. Collagenase clostridium histolyticum (CCH) is currently approved in adults with DC for the nonsurgical treatment of a single palpable cord during a 30-day treatment cycle. This open-label pilot study was designed to examine the safety, efficacy, and multiple-dose pharmacokinetics of injecting two cords (affected joints) with multiple doses of CCH concurrently into the same hand in subjects with DC and multiple contractures.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
United States 1 2%
Italy 1 2%
Unknown 42 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 22%
Researcher 9 20%
Other 4 9%
Student > Bachelor 4 9%
Student > Doctoral Student 3 7%
Other 10 22%
Unknown 5 11%
Readers by discipline Count As %
Medicine and Dentistry 29 64%
Agricultural and Biological Sciences 3 7%
Biochemistry, Genetics and Molecular Biology 1 2%
Earth and Planetary Sciences 1 2%
Business, Management and Accounting 1 2%
Other 2 4%
Unknown 8 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 April 2013.
All research outputs
#17,686,611
of 22,707,247 outputs
Outputs from BMC Musculoskeletal Disorders
#2,883
of 4,028 outputs
Outputs of similar age
#121,999
of 163,363 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#34
of 42 outputs
Altmetric has tracked 22,707,247 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,028 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,363 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.